Calls to Poison Centers about Kratom Skyrocket by Over 1,200% in a Decade, Sparks National Health Concern
The past decade has borne witness to an unprecedented surge in calls made to poison control centers regarding kratom, a botanical substance with growing popularity across the United States. New research led by Dr. Chris Holstege from UVA Health delineates this remarkable escalation, revealing a staggering 1,200% increase in reports between 2015 and 2025. This upswing correlates closely with a dramatic rise in hospitalizations and signals an urgent call to action for the medical community and regulatory agencies alike.
Kratom, derived from the leaves of the Mitragyna speciosa tree indigenous to Southeast Asia, has long been used traditionally in its native regions for its psychoactive and analgesic properties. Contemporary consumers in the U.S., however, encounter kratom in a plethora of forms, ranging from dried leaves to potent extracts and synthetic variants, often laced with unidentified compounds. This transformation in form and accessibility has blurred the lines of safety, as evidenced by the burgeoning incidence of adverse clinical outcomes.
The UVA Health analysis revealed that poison center calls escalated markedly, from a mere 258 in 2015 to a record-setting 3,434 in 2025. This tenfold increase is paralleled by a surge in hospital admissions directly attributable to kratom toxicity. Solely kratom-induced hospitalizations increased by approximately 1,150%, with numbers climbing from 43 cases in 2015 to 538 in 2025. Moreover, cases involving polydrug exposures, where kratom is combined with substances like illicit drugs or prescription antidepressants, surged by nearly 1,300%, rising from 40 to 549 annually.
Hospitalizations alone, however, do not fully capture the public health gravity. The study reported 233 deaths within the analyzed period linked to kratom, with an alarming 184 involving the concurrent use of other substances. This polypharmacy aspect exacerbates the risk profile of kratom, underscoring the complex pharmacodynamics and potential for dangerous drug interactions inherent in its use.
Dr. Holstege emphasizes the clinical implications, observing that the rising trend seen in national data is vividly mirrored in local medical practice. The Blue Ridge Poison Center, which he directs, has noted an influx of patients presenting severe and sometimes life-threatening complications tied to kratom ingestion. These range from acute liver injury to cardiovascular disturbances and neuropsychiatric sequelae, pointing to the multifaceted toxicity kratom can engender.
Traditionally, kratom leaves were consumed via chewing, brewing into teas, or crushing, producing moderate stimulant or sedative effects, depending on dosage and strain. However, modern formulations often concentrate specific alkaloids—particularly mitragynine and 7-hydroxymitragynine—enhancing potency and altering pharmacological profiles. These alkaloids interact with opioid receptors and a multitude of other neurotransmitter systems, creating a complex and sometimes unpredictable spectrum of effects including analgesia, euphoria, and respiratory depression.
Despite its unregulated status in the United States, kratom’s potent bioactive compounds have drawn increasing scrutiny. The absence of quality control measures and standardized dosing protocols leads to widespread variability in product content and strength. This inconsistency raises significant risks for consumers, who may unwittingly ingest dangerously high levels of active alkaloids or adulterants, complicating clinical management and intensifying public health concerns.
Demographically, the surge in kratom-related calls disproportionately involves males, particularly those in their 20s and 30s. However, the data also indicates a notable increase among individuals aged 40 to 59, suggesting a broadening user base. This epidemiological shift demands attention to both prevention efforts and targeted education in diverse population segments at risk.
The temporal pattern of the calls shows a steady increase in the first half of the decade, followed by a plateau between 2020 and 2024, before a sharp resurgence in 2025. This latter spike may correlate with the proliferation of more potent kratom formulations and wider market availability, including distribution through vape shops and convenience stores, making it even more accessible to the general public.
The researchers assert that kratom carries significant medical risks that are often underappreciated by the public, especially when combined with alcohol, prescribed pharmaceuticals, or illicit substances. In 2025 alone, 60% of multi-substance exposure incidents resulted in serious medical outcomes, with half culminating in hospitalization. These findings highlight the imperative for enhanced public health education to dispel misconceptions surrounding kratom’s safety.
In light of these findings, the UVA Health poison experts advocate for heightened regulatory oversight of kratom products. Current federal frameworks do not sufficiently address the complex pharmacological dangers, product inconsistencies, or the potential for harmful interactions. They urge policymakers to consider stricter controls and for increased allocation of resources toward poison prevention and harm reduction programs.
This compelling body of evidence, published in the Centers for Disease Control and Prevention’s Morbidity and Mortality Weekly Report (MMWR), signals a public health crisis in the making. As kratom’s presence in the American marketplace expands, so too does the imperative for rigorous scientific inquiry, regulatory vigilance, and robust community education to mitigate its burgeoning threat.
Subject of Research: Kratom-related poisonings and associated public health impacts based on poison center data analysis.
Article Title: Not explicitly provided in the source content.
News Publication Date: Not explicitly provided in the source content.
Web References: Original research published in the CDC’s Morbidity and Mortality Weekly Report (MMWR).
References: Analysis data derived from the National Poison Data System and UVA Health clinical observations.
Image Credits: UVA Health.
Keywords: Kratom, poison center calls, hospitalizations, mitragynine, 7-hydroxymitragynine, drug interactions, toxicity, public health, opioid withdrawal, polydrug use.
